Advocacy Webpage Graphics Teach It
TEACH addiction medicine by expanding and strengthening our workforce and dispelling stigma
Advocacy Webpage Graphics Standardize It
STANDARDIZE the delivery of individualized addiction treatment so that more patients receive high-quality, evidence-based care
0. Advocacy Webpage Graphics Cover It
COVER addiction medicine in a way that expands patient access to comprehensive, high-quality addiction care

Leading the movement to transform America's addiction treatment infrastructure and expand access to research-validated, results-based care


ASAM Policy Principles

ASAM believes in a future in which addiction prevention, treatment, remission, and recovery are accessible to all, and where they profoundly improve the health of all people. The following principles guide our advocacy and shape ASAM's advocacy priorities:
  • Addiction policy should be guided by - and promote the use of - the latest science and best practices in addiction prevention, treatment, remission, and recovery.  People with addiction deserve compassionate, evidence-based care that addresses the chronic nature of the disease of addiction.
  • Strategic and multifaceted policy solutions are needed to drive the development of a more accessible, effective, robust, and comprehensive addiction prevention and treatment infrastructure.
  • Policies and payment systems should ensure equitable access to comprehensive, high-quality addiction prevention, treatment, and recovery services.
  • Policy should challenge, rather than enforce, cultural misunderstanding, stigma and discrimination about the disease of addiction.
  • Addiction policy and advocacy should respect and integrate the perspectives of people with addiction and their families.

ASAM Urges DEA to Finalize Proposal to Authorize Mobile OTPs

by | Mar 25, 2020

ASAM submitted a letter to the Drug Enforcement Administration (DEA) urging it to finalize its proposed rule to allow Opioid Treatment Programs (OTPs) to operate mobile units without requiring them to obtain a separate registration. The proposal to waive the requirement for a separate registration for a mobile component will allow OTPs to expand their reach and deliver evidence-based treatment services for opioid use disorder (OUD) to patients who may not otherwise be able to access such services.

In part due to the intensity of the regulatory requirements that OTPs must meet, there is insufficient OTP capacity to meet treatment need. OTPs are also not always geographically accessible to patients who need methadone treatment. A recent study found that patients in rural counties must drive longer distances to reach an OTP than patients in urban counties.
By allowing mobile components of registered OTPs to be considered a coincident activity, this proposed rule would reduce the costs of expanding an OTP’s geographic reach and increase access to treatment. 

Read ASAM's full letter here